Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that ...

Getting experience with the specialized niche of ophthalmic imaging as a student helps grad secure a summer internship with ...

Retina World Congress 2025 unites global retina experts in Fort Lauderdale to explore cutting-edge research, surgical ...

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

A renowned health expert says certain foods could be the cause of pressure and discomfort behind your eyes. Dr Eric Berg is a ...

Epiretinal membrane removal leads to significant anatomical changes that are more pronounced in eyes without glaucoma.

New research suggests a path forward that could change the lives of millions who are losing vision due to retinal damage and conditions like macular degeneration and glaucoma.

We believe this technique could potentially transform treatment paradigms for retinal degenerative conditions.” Nie and her ...

After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull ...